KLK3 and prostate carcinoma: Other author used the new ASTRO-Phoenix definition of biochemical failure (i.e., PSA nadir plus 2 ng/ml): According to this definition, overall five-years bNED reached was 77%[23] in patients with low-intermediate risk prostate cancer.